Trial
NCT03768726
Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Bipolar Disorder
Intervention
Ziprasidone
Why stopped
Pfizer has decided to perform the pre-specified final analysis at the current enrollment using a re-estimation of the sample size.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-16